AllianceBernstein’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,093,199
| Closed | -$6.59M | – | 3211 |
|
|
2019
Q4 | $6.59M | Buy |
1,093,199
+899,799
| +465% | +$5.21M | ﹤0.01% | 1271 |
|
|
2019
Q3 | $696K | Sell |
193,400
-20,700
| -10% | -$79.8K | ﹤0.01% | 2409 |
|
|
2019
Q2 | $574K | Buy |
214,100
+17,200
| +9% | +$50.8K | ﹤0.01% | 2543 |
|
|
2019
Q1 | $583K | Sell |
196,900
-1,400
| -0.7% | -$3.44K | ﹤0.01% | 2465 |
|
|
2018
Q4 | $315K | Buy |
198,300
+13,200
| +7% | +$37.3K | ﹤0.01% | 2710 |
|
|
2018
Q3 | $681K | Hold |
185,100
| – | – | ﹤0.01% | 2504 |
|
|
2018
Q2 | $524K | Buy |
185,100
+26,000
| +16% | +$88.6K | ﹤0.01% | 2593 |
|
|
2018
Q1 | $590K | Buy |
159,100
+17,700
| +13% | +$57.9K | ﹤0.01% | 2473 |
|
|
2017
Q4 | $407K | Sell |
141,400
-29,800
| -17% | -$108K | ﹤0.01% | 2598 |
|
|
2017
Q3 | $769K | Hold |
171,200
| – | – | ﹤0.01% | 2415 |
|
|
2017
Q2 | $786K | Sell |
171,200
-12,200
| -7% | -$49K | ﹤0.01% | 2419 |
|
|
2017
Q1 | $772K | Sell |
183,400
-16,963
| -8% | -$70.4K | ﹤0.01% | 2367 |
|
|
2016
Q4 | $827K | Buy |
200,363
+163
| +0.1% | +$866 | ﹤0.01% | 2355 |
|
|
2016
Q3 | $1.62M | Hold |
200,200
| – | – | ﹤0.01% | 1930 |
|
|
2016
Q2 | $1.56M | Hold |
200,200
| – | – | ﹤0.01% | 1923 |
|
|
2016
Q1 | $1.55M | Buy |
200,200
+1,860
| +0.9% | +$13.6K | ﹤0.01% | 1808 |
|
|
2015
Q4 | $2.14M | Sell |
198,340
-3,360
| -2% | -$30.5K | ﹤0.01% | 1558 |
|
|
2015
Q3 | $1.39M | Sell |
201,700
-3,460,382
| -94% | -$28.2M | ﹤0.01% | 1942 |
|
|
2015
Q2 | $32.4M | Buy |
3,662,082
+37,751
| +1% | +$357K | 0.03% | 578 |
|
|
2015
Q1 | $35.7M | Buy |
3,624,331
+3,458,131
| +2,081% | +$43.2M | 0.03% | 562 |
|
|
2014
Q4 | $2.04M | Sell |
166,200
-25,000
| -13% | -$305K | ﹤0.01% | 1739 |
|
|
2014
Q3 | $1.91M | Hold |
191,200
| – | – | ﹤0.01% | 1757 |
|
|
2014
Q2 | $1.45M | Buy |
191,200
+44,000
| +30% | +$176K | ﹤0.01% | 2012 |
|
|
2014
Q1 | $484K | Buy |
147,200
+2,600
| +2% | +$9.1K | ﹤0.01% | 2444 |
|
|
2013
Q4 | $480K | Sell |
144,600
-40,900
| -22% | -$119K | ﹤0.01% | 2463 |
|
|
2013
Q3 | $560K | Buy |
185,500
+7,703
| +4% | +$52.8K | ﹤0.01% | 2414 |
|
|
2013
Q2 | $1.45M | Buy |
+177,797
| New | +$1.36M | ﹤0.01% | 1844 |
|
AllianceBernstein's ACHN Position: Q1 2020 in Review
AllianceBernstein sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 1,093,199 shares — an estimated $6.59M sold.
AllianceBernstein first reported a position in ACHN in Q2 2013 and held it in 27 quarters. The position peaked at $35.7M in Q1 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- AllianceBernstein reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- AllianceBernstein sold 1,093,199 Achillion Pharmaceuticals shares in Q1 2020, an estimated $6.59M.
- AllianceBernstein first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 27 quarters.
- AllianceBernstein's Achillion Pharmaceuticals position peaked at $35.7M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on AllianceBernstein's 13F filing for Q1 2020, filed 14 May 2020.